Tetsuro Kondo Selected Research

Oral Hemorrhage

2/2013

Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuro Kondo Research Topics

Disease

24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 05/2003
8	Neoplasms (Cancer) 01/2024 - 01/2007
5	Neutropenia 01/2018 - 01/2007
4	Disease Progression 01/2024 - 02/2010
4	Carcinoma (Carcinomatosis) 10/2017 - 01/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2011
3	Pneumonia (Pneumonitis) 12/2020 - 02/2010
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2013 - 07/2006
2	Lung Neoplasms (Lung Cancer) 04/2024 - 09/2014
2	Febrile Neutropenia 03/2013 - 02/2013
2	Fatigue 02/2013 - 02/2010
2	Diarrhea 02/2013 - 05/2003
2	Thymoma (Thymic Carcinoma) 09/2009 - 01/2007
1	Small Cell Carcinoma 01/2024
1	Adenocarcinoma 01/2024
1	Premature Birth (Birth, Premature) 01/2023
1	Tuberculosis (Tuberculoses) 06/2021
1	Thrombocytopenia (Thrombopenia) 05/2017
1	Hyponatremia 02/2013
1	Oral Hemorrhage 02/2013
1	Vomiting 02/2013
1	Hypotension (Low Blood Pressure) 02/2013
1	Adenocarcinoma of Lung 01/2013
1	Vasculitis (Vasculitides) 01/2013
1	Fever (Fevers) 01/2013
1	Hypersensitivity (Allergy) 02/2010
1	Anorexia 02/2010
1	Lymphatic Metastasis 09/2009

Drug/Important Bio-Agent (IBA)

11	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 05/2003
9	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 02/2004
8	nedaplatinIBA 01/2018 - 01/2011
4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2013
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2017 - 02/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 07/2006
3	PlatinumIBA 01/2024 - 07/2007
3	Docetaxel (Taxotere)FDA Link 01/2018 - 05/2005
2	Pemetrexed (MTA)FDA Link 01/2023 - 12/2019
2	AntibodiesIBA 12/2020 - 01/2013
2	ParaffinIBA 10/2017 - 08/2014
2	Formaldehyde (Formol)FDA Link 10/2017 - 08/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2014
2	ErbB Receptors (EGF Receptor)IBA 08/2014 - 01/2010
2	Gefitinib (Iressa)FDA Link 01/2012 - 02/2010
2	Methylprednisolone FDA LinkGeneric 09/2009 - 01/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009 - 01/2007
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	B7-H1 AntigenIBA 01/2024
1	MucinsIBA 01/2024
1	durvalumabIBA 01/2024
1	CytokinesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	pembrolizumabIBA 06/2021
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 09/2014
1	Peptides (Polypeptides)IBA 09/2014
1	CreatinineIBA 03/2013
1	TegafurIBA 03/2013
1	UracilIBA 03/2013
1	amrubicinIBA 03/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2012
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2010
1	Anaplastic Lymphoma KinaseIBA 09/2010
1	Alanine Transaminase (SGPT)IBA 02/2010
1	Gemcitabine FDA Link 07/2007
1	Carboplatin (JM8)FDA LinkGeneric 07/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2004
1	baicalinIBA 05/2003
1	beta-glucuronidase inhibitorIBA 05/2003
1	hange-shashintoIBA 05/2003

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2024 - 07/2006
9	Therapeutics 01/2023 - 01/2007
6	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 02/2004
5	Aftercare (After-Treatment) 01/2023 - 07/2007
4	Radiotherapy 01/2024 - 01/2007
2	Induction Chemotherapy 01/2023 - 09/2009
1	Chemoradiotherapy 01/2024
1	Perinatal Care 01/2023
1	Immunotherapy 12/2020
1	Adjuvant Chemotherapy 01/2018
1	Molecular Targeted Therapy 10/2017
1	Operative Surgical Procedures 08/2012
1	Pneumonectomy (Lung Volume Reduction) 09/2009
1	Metastasectomy 09/2009
1	Thymectomy 09/2009
1	Kampo Medicine (Kampo) 05/2003